Management of patients with ovarian cancer in the COVID‐19 era

At the beginning of 2020, coronavirus disease 2019 (COVID‐19) spreads worldwide. Patients with ovarian cancer should be considered at high‐risk of developing severe morbidity related to COVID‐19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Surg Oncol
Egile Nagusiak: Bogani, Giorgio, Casarin, Jvan, Pinelli, Ciro, Di Donato, Violante, Bosio, Sara, Ruisi, Simona, Brusadelli, Claudia, Guerrisi, Rocco, Sarpietro, Giuseppe, Ditto, Antonino, Ghezzi, Fabio, Raspagliesi, Francesco
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Commentary
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300981/
https://ncbi.nlm.nih.gov/pubmed/32476155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.26057
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak